| Breakdown | Mar 2025 | Mar 2024 | Mar 2024 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 56.87M | 55.65M | 48.09M | 32.86M | 52.55M |
| Gross Profit | 54.72M | 24.91M | 17.91M | 13.51M | 25.01M |
| EBITDA | 3.94M | 3.05M | -1.83M | -40.00K | 10.50M |
| Net Income | 566.00K | 765.00K | -3.55M | -5.52M | 6.51M |
Balance Sheet | |||||
| Total Assets | 76.95M | 77.25M | 78.30M | 51.96M | 66.62M |
| Cash, Cash Equivalents and Short-Term Investments | 23.01M | 25.41M | 24.93M | 9.63M | 25.28M |
| Total Debt | 8.02M | 9.55M | 12.29M | 13.26M | 14.23M |
| Total Liabilities | 37.92M | 37.41M | 38.68M | 25.99M | 33.55M |
| Stockholders Equity | 39.03M | 39.84M | 39.62M | 25.97M | 33.06M |
Cash Flow | |||||
| Free Cash Flow | 2.95M | 6.71M | 1.38M | -11.11M | 7.90M |
| Operating Cash Flow | 3.02M | 6.92M | 1.66M | -10.34M | 8.53M |
| Investing Cash Flow | -364.00K | 293.00K | 11.59M | -1.92M | 879.00K |
| Financing Cash Flow | -5.45M | -6.73M | -1.89M | -3.39M | -4.47M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | £6.80M | 22.12 | 12.70% | 2.64% | ― | ― | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | £117.25M | 8.00 | 14.26% | ― | 57.11% | ― | |
61 Neutral | £3.80M | 0.53 | 66.17% | 26.13% | ― | ― | |
60 Neutral | £35.00M | 42.50 | 3.68% | 7.96% | 2.19% | -26.09% | |
50 Neutral | £18.01M | -21.88 | -10.57% | ― | -32.90% | -57.89% |